Results of the multicenter natural interferon-α treatment for chronic hepatitis C: Correlation between total dose, administration periods and efficacy of therapy

Hidetsugu Saito, Hirotoshi Ebinuma, Masaya Oda, Hiromasa Ishii, Keio Natural

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The efficacy of different doses and administration periods of interferon (IFN)-α treatment for patients with chronic hepatitis C was retrospectively evaluated by using the return of serum alanine aminotransferase (ALT) to normal levels 12 months after therapy as an index. Two hundred forty-one patients with chronic hepatitis C received 6 to 9 mega units of IFN-α once, twice, or three times per week for a different number of weeks. ALT levels generally returned to normal in 77 of the 241 patients (32.0%). The efficacy of IFN-α therapy with a total dose of 350 mega units or more was significantly superior to that with 350 mega units or less (30 to 45%, p < 0.05). However, the efficacy was the same if a total dose was more than 350 mega units, and more than 700 mega units did not improve the response rate. Administration periods of more than 6 months and less than 1 year appeared to be the most effective in this study. To achieve a complete response, administration three times a week was better than once a week. The higher the dose administered within a certain period, the higher was the efficacy of the IFN-α treatment. However, the factors affecting response must be further studied, because there are patients who respond to therapy with a total of only about 200 mega units, and patients who do not respond even to 800 mega units given for more than 1 year.

Original languageEnglish
Pages (from-to)177-183
Number of pages7
JournalKeio Journal of Medicine
Volume46
Issue number4
Publication statusPublished - 1997 Dec

Fingerprint

Chronic Hepatitis C
Interferons
Alanine Transaminase
Therapeutics
Serum

Keywords

  • Chronic hepatitis C
  • Efficacy of interferon therapy
  • Interferon-α

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Results of the multicenter natural interferon-α treatment for chronic hepatitis C : Correlation between total dose, administration periods and efficacy of therapy. / Saito, Hidetsugu; Ebinuma, Hirotoshi; Oda, Masaya; Ishii, Hiromasa; Natural, Keio.

In: Keio Journal of Medicine, Vol. 46, No. 4, 12.1997, p. 177-183.

Research output: Contribution to journalArticle

@article{9dd344a8955a4b3281e127bacc1a12e7,
title = "Results of the multicenter natural interferon-α treatment for chronic hepatitis C: Correlation between total dose, administration periods and efficacy of therapy",
abstract = "The efficacy of different doses and administration periods of interferon (IFN)-α treatment for patients with chronic hepatitis C was retrospectively evaluated by using the return of serum alanine aminotransferase (ALT) to normal levels 12 months after therapy as an index. Two hundred forty-one patients with chronic hepatitis C received 6 to 9 mega units of IFN-α once, twice, or three times per week for a different number of weeks. ALT levels generally returned to normal in 77 of the 241 patients (32.0{\%}). The efficacy of IFN-α therapy with a total dose of 350 mega units or more was significantly superior to that with 350 mega units or less (30 to 45{\%}, p < 0.05). However, the efficacy was the same if a total dose was more than 350 mega units, and more than 700 mega units did not improve the response rate. Administration periods of more than 6 months and less than 1 year appeared to be the most effective in this study. To achieve a complete response, administration three times a week was better than once a week. The higher the dose administered within a certain period, the higher was the efficacy of the IFN-α treatment. However, the factors affecting response must be further studied, because there are patients who respond to therapy with a total of only about 200 mega units, and patients who do not respond even to 800 mega units given for more than 1 year.",
keywords = "Chronic hepatitis C, Efficacy of interferon therapy, Interferon-α",
author = "Hidetsugu Saito and Hirotoshi Ebinuma and Masaya Oda and Hiromasa Ishii and Keio Natural",
year = "1997",
month = "12",
language = "English",
volume = "46",
pages = "177--183",
journal = "Keio Journal of Medicine",
issn = "0022-9717",
publisher = "Keio University School of Medicine",
number = "4",

}

TY - JOUR

T1 - Results of the multicenter natural interferon-α treatment for chronic hepatitis C

T2 - Correlation between total dose, administration periods and efficacy of therapy

AU - Saito, Hidetsugu

AU - Ebinuma, Hirotoshi

AU - Oda, Masaya

AU - Ishii, Hiromasa

AU - Natural, Keio

PY - 1997/12

Y1 - 1997/12

N2 - The efficacy of different doses and administration periods of interferon (IFN)-α treatment for patients with chronic hepatitis C was retrospectively evaluated by using the return of serum alanine aminotransferase (ALT) to normal levels 12 months after therapy as an index. Two hundred forty-one patients with chronic hepatitis C received 6 to 9 mega units of IFN-α once, twice, or three times per week for a different number of weeks. ALT levels generally returned to normal in 77 of the 241 patients (32.0%). The efficacy of IFN-α therapy with a total dose of 350 mega units or more was significantly superior to that with 350 mega units or less (30 to 45%, p < 0.05). However, the efficacy was the same if a total dose was more than 350 mega units, and more than 700 mega units did not improve the response rate. Administration periods of more than 6 months and less than 1 year appeared to be the most effective in this study. To achieve a complete response, administration three times a week was better than once a week. The higher the dose administered within a certain period, the higher was the efficacy of the IFN-α treatment. However, the factors affecting response must be further studied, because there are patients who respond to therapy with a total of only about 200 mega units, and patients who do not respond even to 800 mega units given for more than 1 year.

AB - The efficacy of different doses and administration periods of interferon (IFN)-α treatment for patients with chronic hepatitis C was retrospectively evaluated by using the return of serum alanine aminotransferase (ALT) to normal levels 12 months after therapy as an index. Two hundred forty-one patients with chronic hepatitis C received 6 to 9 mega units of IFN-α once, twice, or three times per week for a different number of weeks. ALT levels generally returned to normal in 77 of the 241 patients (32.0%). The efficacy of IFN-α therapy with a total dose of 350 mega units or more was significantly superior to that with 350 mega units or less (30 to 45%, p < 0.05). However, the efficacy was the same if a total dose was more than 350 mega units, and more than 700 mega units did not improve the response rate. Administration periods of more than 6 months and less than 1 year appeared to be the most effective in this study. To achieve a complete response, administration three times a week was better than once a week. The higher the dose administered within a certain period, the higher was the efficacy of the IFN-α treatment. However, the factors affecting response must be further studied, because there are patients who respond to therapy with a total of only about 200 mega units, and patients who do not respond even to 800 mega units given for more than 1 year.

KW - Chronic hepatitis C

KW - Efficacy of interferon therapy

KW - Interferon-α

UR - http://www.scopus.com/inward/record.url?scp=0031443554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031443554&partnerID=8YFLogxK

M3 - Article

C2 - 9444929

AN - SCOPUS:0031443554

VL - 46

SP - 177

EP - 183

JO - Keio Journal of Medicine

JF - Keio Journal of Medicine

SN - 0022-9717

IS - 4

ER -